Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Company Info
| ISIN | US21833P1030 |
|---|---|
| CUSIP | 21833P103 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $412.30M |
|---|---|
| EPS | -$10.31 |
| Gross Profit (TTM) | -$16.14M |
| EBITDA (TTM) | -$44.44M |
| Year Range | $3.03 - $49.87 |
| Target Price | $55.00 |
| Short % | 5.62% |
| Short Ratio | 1.24 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: CRBP vs. SPY
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Corbus Pharmaceuticals Holdings, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Corbus Pharmaceuticals Holdings, Inc. had a return of 454.64% year-to-date (YTD) and 335.63% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 454.64% | 5.84% |
| 1 month | -7.33% | -2.98% |
| 6 months | 553.02% | 22.02% |
| 1 year | 335.63% | 24.47% |
| 5 years (annualized) | -31.48% | 11.44% |
| 10 years (annualized) | N/A | 10.46% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 338.58% | 16.65% | 26.99% | |||||||||
| 2023 | -7.67% | -19.14% | 22.75% | -9.72% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Corbus Pharmaceuticals Holdings, Inc.(CRBP)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Corbus Pharmaceuticals Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Corbus Pharmaceuticals Holdings, Inc. was 99.31%, occurring on Mar 10, 2023. The portfolio has not yet recovered.
The current Corbus Pharmaceuticals Holdings, Inc. drawdown is 89.21%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.31% | Mar 21, 2017 | 1504 | Mar 10, 2023 | — | — | — |
| -78.79% | Dec 8, 2014 | 296 | Feb 10, 2016 | 146 | Sep 8, 2016 | 442 |
| -50.97% | Oct 10, 2016 | 19 | Nov 3, 2016 | 92 | Mar 20, 2017 | 111 |
| -34.44% | Nov 14, 2014 | 7 | Nov 24, 2014 | 8 | Dec 5, 2014 | 15 |
| -17.44% | Sep 20, 2016 | 4 | Sep 23, 2016 | 8 | Oct 5, 2016 | 12 |
Volatility
Volatility Chart
The current Corbus Pharmaceuticals Holdings, Inc. volatility is 22.47%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |